News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast 11/21/2014
Isis Pharmaceuticals, Inc. (ISIS) Release: ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca PLC (AZN) At European Cancer Symposium 11/21/2014
BioSpecifics Technologies Corporation (BSTC) Announces New Data On XIAFLEX For Peyronie's Disease Presented At SMSNA Scientific Meeting 11/21/2014
Rock Creek Pharmaceuticals To Present At The Biotech Showcase 2015 11/21/2014
Immunomedics, Inc. (IMMU) Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Piper Jaffray Healthcare Conference 11/21/2014
Depomed, Inc. (DEPO) To Present At Piper Jaffray 26th Annual Healthcare Conference 11/21/2014
INSYS Therapeutics To Present At 26th Annual Piper Jaffray Healthcare Conference 11/21/2014
Vertex Pharmaceuticals (MA) (VRTX) To Present At Deutsche Bank (DB) BioFEST On December 2 11/21/2014
Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank (DB) 2014 BioFEST 11/21/2014
ReVance Therapeutics, Inc. (RVNC) Announces Participation In 26th Annual Piper Jaffray Healthcare Conference 11/21/2014
Verastem, Inc. (VSTM) Presents Data At The 2014 EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014
Lion Biotechnologies, Inc. Announces Clinical Data Update At American Society of Hematology Annual Meeting 11/21/2014
Bionomics Limited (BNO.AX) Release: BNC101 Data To Be Presented At European Cancer Conference 11/21/2014
SYGNIS AG To Present At Upcoming Investor Conferences 11/21/2014
Lucideon (Formerly Known As CERAM) To Hold Free Breakfast Forum – ‘Materials In Extreme Environments’ – 12 December 2014 11/21/2014
AcelRx Pharmaceuticals (ACRX) To Participate In Four Upcoming Investor Events 11/20/2014
Clinical Data Of MediGene AG (MDGEF.PK)'s Dendritic Cell Vaccines To Be Presented At American Society of Hematology Conference 11/20/2014
Auxilium Pharmaceuticals (AUXL) Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting 11/20/2014
DATATRAK International, Inc. (DATA) To Present At The LD Micro Conference 11/20/2014
Organovo To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/20/2014
Organovo Holdings, Inc. To Provide Corporate Update And Investor Presentation In A Live, Interactive Webcast On December 4 11/20/2014
The Macula Vision Research Foundation (MVRF) To Host Free Supportsight(SM) Seminars On Age-Related Macular Degeneration 11/20/2014
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In December 11/20/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At 26th Annual Piper Jaffray Healthcare Conference 11/20/2014
Audentes Therapeutics To Present At Piper Jaffray Healthcare Conference 11/20/2014
Biogen Idec (BIIB) To Present At The 2014 Deutsche Bank (DB) BioFEST Conference 11/20/2014
Eagle Pharmaceuticals (EGRX) To Present At Piper Jaffray 2014 Healthcare Conference 11/20/2014
RetroSense Therapeutics Receives Second "Top Project To Watch" Nomination 11/20/2014
IntelGenx Corp. To Present At Singular Research's Best Of The Uncovered 2014 NYC Fall Conference 11/20/2014
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014
Biocryst Pharmaceuticals (BCRX) To Present At Two Upcoming Investor Conferences 11/20/2014
Integra LifeSciences Holdings Corporation (IART) To Participate In The Piper Jaffray And Oppenheimer Healthcare Conferences In December 11/20/2014
Auxilium Pharmaceuticals (AUXL) Presents STENDRA Data At SMSNA Scientific Meeting 11/20/2014
OXiGENE (OXGN) Announces Preclinical Poster Presentation On Oxi4503 At Upcoming American Society of Hematology Meeting 11/20/2014
StemCells Inc. (STEM)To Host Inaugural Investor And Analyst Event In New York 11/20/2014
Matinas BioPharma To Present At Two Investor Conferences In Early December 11/20/2014
Immunomedics, Inc. (IMMU) Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy 11/20/2014
Otonomy, Inc. (OTIC) To Present At The Piper Jaffray Healthcare Conference 11/20/2014
BG Medicine (BGMD) Welcomes Presentation Of Clinical Data On Galectin-3 Testing At The American Heart Association 2014 Scientific Sessions Conference 11/20/2014
Horizon Pharma plc.  (HZNP) Announces Presentation Of Data Showing Unmet Need In Rheumatoid Arthritis And The Positive Effect Of RAYOS® (Prednisone) Delayed-Release Tablets In Reducing Joint Stiffness Of RA Throughout The Day 11/20/2014
Bacterin To Present At The Singular Research 9th Annual Best Of The Uncovereds Conference 11/19/2014
Tokai Pharmaceuticals (TKAI) Presents Updated Interim Galeterone ARMOR2 Data Showing Activity In Patients With Castration-Resistant Prostate Cancer (CRPC) Including Those Showing A Variant Form Of Prostate Cancer Resistant To Hormone Therapy 11/19/2014
Sangamo BioSciences, Inc. (SGMO) Presents Study At Society for Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms 11/19/2014
Exosome Diagnostics Demonstrates Superior Mutation Detection Utilizing Combined Exosomal RNA (exoRNA) And Cell-Free DNA (cfDNA) Isolation And Analysis 11/19/2014
Mast Therapeutics (MSTX) Release: New Data From Nonclinical Heart Failure Study To Be Presented At American Heart Association Conference 11/19/2014
Omni Bio Pharmaceutical Announces Phase 1/2 Clinical Data Of AAT In Myocardial Infarction At American Heart Association Scientific Session 11/19/2014
Champions Oncology, Inc. (CSBR) Release: Presentations At 26th Champions Oncology, Inc. (CSBR)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium Highlight Champions Oncology TumorGrafts' Ability To Evaluate Immune-Modulating Therapies And Guide Clinical Development Strategies 11/19/2014
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014
Kite Pharma, Inc. (KITE) Announces Presentations At The Upcoming 56th American Society of Hematology Annual Meeting 11/19/2014
Adamas Pharmaceuticals (ADMS) To Present At Piper Jaffray Healthcare Conference 11/19/2014
Sangamo BioSciences, Inc. (SGMO) Announces Presentation At The 26th Annual Piper Jaffray Healthcare Conference 11/19/2014
BioMarin Pharmaceutical Inc. (BMRN) To Attend Upcoming Investor Conferences 11/19/2014
Mirati Therapeutics  (MRTX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/19/2014
Zynerba Pharmaceuticals To Present At Oppenheimer 25th Annual Healthcare Conference 2014 11/19/2014
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014
Synta Pharmaceuticals (SNTA) Announces Presentation On Hsp90 inhibitor Drug Conjugate Platform At 26th EORTC-NCI-AACR Symposium 11/19/2014
Catalent, Inc. To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/19/2014
Ligand Pharmaceuticals Inc. (LGND) Provides Highlights From Today’s Analyst Day Event 11/19/2014
Zoetis (ZTS) Outlines Strategy And Initiatives Underway To Drive Growth And Create Shareholder Value At Investor Day Meeting 11/19/2014
Ignyta (RXDX) Announces RXDX-101 Presentations At The 2014 EORTC-NCI-AACR "Molecular Targets And Cancer Therapeutics" Conference 11/19/2014
Fluidigm Corporation Announces New High Throughput Workflow For Single-Cell mRNA Sequencing 11/19/2014
Juventas Therapeutics, Inc. Presents Phase 2 Data At American Heart Association Scientific Sessions That Shows JVS-100 Is Safe, Potentially Effective In Patients With Critical Limb Ischemia 11/18/2014
Isis Pharmaceuticals, Inc. (ISIS) To Host Webcast To Discuss ISIS-FXI Rx Data Presented At The American Society of Hematology Annual Meeting 11/18/2014
KineMed, Inc. Biomarker Studies In Chronic Lymphocytic Leukemia Reveal Groundbreaking Approach For Guiding Patient Management And Drug Development 11/18/2014
International Stem Cell Corporation To Present Preclinical Parkinson's Disease Data At Neuroscience 2014 11/18/2014
FDA's Janet Woodcock, European Medicines Agency's Emer Cooke Headline Parenteral Drug Association Quality Metrics Conference 11/18/2014
Media Advisory - Oncolytics Biotech Inc. (ONC.TO) To Participate In The Stifel 2014 Healthcare Conference 11/18/2014
Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" And Will Present At The Therapeutic Area Partnerships Conference 11/18/2014
Debiopharm Group Presents Advances Of Two Key Oncology Clinical Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium In Barcelona 11/18/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In December 11/18/2014
Thirteen Poster Abstracts Chronicling The Clinical Use, Cost Effectiveness And Accelerated Healing Results Of Mimedx Products To Be Presented By VA Physicians At Desert Foot Conference 11/18/2014
Proteon Therapeutics, Inc. (PRTO) To Present At The Stifel Nicolaus 2014 Healthcare Conference November 18th 11/18/2014
BioLink 2015 Will Be Held On Jan 22, 2015, With A Focus On Biopharma Industrial Innovation & International Technology Transfer 11/18/2014
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Stifel Nicolaus 2014 Healthcare Conference 11/18/2014
Cedars-Sinai Heart Institute Release: Cardiac Stem Cell Therapy May Heal Heart Damage Caused By Duchenne Muscular Dystrophy 11/18/2014
TAP Biosystems Release: New ambr® 15 Webinar On Overcoming Bottlenecks In Cell Line Development Features Data Showing How This Technology Can Improve Biologics Manufacturing 11/18/2014
Helsinn CEO Riccardo Braglia To Present At The Jefferies and Co. 2014 Healthcare Conference 11/18/2014
Safety And Feasibility Of Cytori Therapeutics, Inc. (CYTX) Cell Therapy In Acute Myocardial Infarction Presented At 2014 American Heart Association Meeting 11/18/2014
Trevi Therapeutics To Present At The Stifel 2014 Healthcare Conference 11/18/2014
Nodality, Inc. Announces Data Presentation From Collaborative Program With UCB Pharma (UCBJF.PK) At American College of Rheumatology 2014 Annual Meeting 11/18/2014
Research Presented By Oxford University At American Heart Association Annual Meeting Shows Extent Of Damage Caused By Smoking 11/18/2014
Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of RP6530 (Dual PI3K Delta/Gamma Inhibitor) In Multiple Myeloma 11/18/2014
Raptor Pharmaceutical Inc. (RPTP) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/18/2014
NeuralStem Inc. NSI-189 Phase Ib Major Depression Disorder Neurogenic Biomarker Data Presented At The CNS Summit 11/17/2014
AbbVie (ABBV) Presents Results From Study Of ABT-414 In Patients With Glioblastoma Multiforme At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/17/2014
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Late-Breaking Presentation Of Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 11/17/2014
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014
CTI BioPharma To Present At The Upcoming Investor Conferences 11/17/2014
Asterias Biotherapeutics To Participate In Live Google Inc. Hangout Discussion Of Stem Cell-Based Therapies For Spinal Cord Injury 11/17/2014
AbbVie (ABBV) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014
Epic Sciences To Present Data On A Combination CTC And cfDNA Assay For Molecular Targets Of Non-Small Cell Lung Cancer Therapies At The 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/17/2014
Dipexium Pharmaceuticals (DPRX) Announces Presentation At Oppenheimer 25th Annual Healthcare Conference 11/17/2014
Aptose Biosciences To Present At The Stifel 2014 Healthcare Conference 11/17/2014
Kindred Bio (KIN) To Present At Jefferies 2014 Global London Healthcare Conference 11/17/2014
AbbVie (ABBV)To Present Data On Investigational Oncology Compounds At The 56th American Society of Hematology Annual Meeting 11/17/2014
Rexahn Pharmaceuticals, Inc. (RNN) To Participate In Brean Capital 2014 Life Sciences Summit 11/17/2014
Amgen (AMGN) To Present At The Jefferies and Co. Global Healthcare Conference 11/17/2014
OncoGenex Pharmaceuticals Inc. (OGXI) To Present At The Stifel 2014 Healthcare Conference 11/17/2014
Mologen AG (MOLGF.PK): Presentation On IMPACT Study At ESMO Symposium On Immuno-Oncology 11/17/2014
Relypsa, Inc. (RLYP) Announces Key Data Presented At American Society of Nephrology On Long-Term Chronic Treatment And Early Onset Of Action With Patiromer For Oral Suspension 11/17/2014
Nuo Therapeutics To Sponsor Pre-Event For 35th National Veterans Wheelchair Games 11/17/2014
Hemispherx Biopharma (HEB) Reports on Annual Stockholder Meeting 11/17/2014
KYTHERA Biopharmaceuticals, Inc. (KYTH) To Present At The Goldman, Sachs & Co. US Emerging / SMID Cap Growth Conference 11/17/2014
Ablynx (ABLYF) To Present At The Jefferies and Co. 2014 Global Healthcare Conference In London 11/17/2014
NewLink Genetics To Participate In The Upcoming Stifel, Jefferies and Co., And Piper Jaffray Healthcare Conferences 11/17/2014
Radius Health To Present At The Jefferies and Co. 2014 Global London Healthcare Conference 11/17/2014
Cancer Genetics, Inc. (CGIX) To Present At American Society of Hematology Annual Meeting 11/17/2014
Mast Therapeutics (MSTX) To Present MST-188 Data At 2014 American Society of Hematology Conference 11/17/2014
Amarantus To Host Business Update Conference Call On November 18, 2014 11/17/2014
Flexion Therapeutics (FLXN) To Present At Stifel Healthcare Conference 2014 11/17/2014
IMRIS CEO Jay D. Miller To Present At The Canaccord Genuity Medical Technologies & Diagnostics Forum 11/17/2014
Can-Fite BioPharma (CFBI) Announces Special General Meeting Of Shareholders To Elect External Director 11/17/2014
GW Pharmaceuticals To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014
TherapeuticsMD, Inc.  (TXMD) To Present At The Stifel Healthcare Conference 11/17/2014
Dicerna Pharmaceuticals (DRNA) To Present At Two Upcoming Investor Conferences 11/17/2014
Arrowhead Research Corporation (ARWR) To Present At Upcoming Conferences 11/17/2014
Galapagos NV (GLPG.BR) Presents Clean Drug-Drug Interaction Profile With GLPG0634 (Filgotinib) At ACR 2014 11/17/2014
Data From EPIRUS Biopharmaceuticals’ Phase 3 Study Of BOW015, A Biosimilar Infliximab, To Be Presented As A Late Breaking Poster At American College of Rheumatology Annual Meeting 11/17/2014
Osiris Therapeutics, Inc. (OSIR) To Present At The Canaccord Genuity Medical Technology And Diagnostics Forum 11/17/2014
Nodality, Inc. Announces Data Presentations From Systemic Lupus Erythematosus Collaborative Programs At American College of Rheumatology 2014 Annual Meeting 11/17/2014
Incyte Corporation (INCY) To Present At Upcoming Investor Conferences 11/17/2014
Aratana Therapeutics (PETX) To Present At Jefferies and Co. Global Healthcare Conference 11/17/2014
Bionomics Limited (BNO.AX) To Present BNC210 At Society For Neuroscience Meeting 11/17/2014
Naurex Inc. Release: Data Presented At Society For Neuroscience Demonstrates That Naurex's GLYX-13 Enhances Synaptic Plasticity Through NMDA Receptor Modulation 11/17/2014
AstraZeneca PLC (AZN) Presents Data From Phase 3 Studies Of Lesinurad In Combination With Allopurinol In Gout Patients At American College of Rheumatology 2014 Annual Meeting 11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Five Prime Therapeutics, Inc. (FPRX) To Present Data From Healthy Volunteer Cohorts In Phase 1 Trial Of FPA008 At The 2014 American College of Rheumatology/ARHP Annual Scientific Meeting 11/14/2014
PTC Therapeutics, Inc. (PTCT) To Webcast Upcoming Science Day And Investor Conferences 11/14/2014
UCB, Inc. (UCBJF.PK) Shows Strong Scientific Presence At Leading Rheumatology Meeting 11/14/2014
Essentialis To Present Clinical Update At The Annual Research Conference Of The Foundation For Prader-Willi Research 11/14/2014
Isis Pharmaceuticals, Inc. (ISIS) To Present At Upcoming Investor Conferences 11/14/2014
NeuroPhage Pharmaceuticals, Inc.'s GAIM Technology Chosen As 'Top Project To Watch' For The Therapeutic Area Partnerships Conference 11/14/2014
PTC Therapeutics, Inc. (PTCT) Recognized For Outstanding Innovation At The 2014 Rare & Orphan Advocacy And Research (ROAR) Awards 11/14/2014
Virobay Inc. To Present Data On Two Cathepsin S Inhibitor Programs In Neuropathic Pain And Alzheimer's Disease At The 2014 Society for Neuroscience Annual Meeting 11/14/2014
Cord Blood Registry Release: New Autism Study Safety Data To Be Presented At The Translational Neuroscience Cell Symposium 11/14/2014
Harvard Bioscience Inc. (HBIO) To Exhibit At Society For Neuroscience 2014 Annual Meeting In Washington, DC On November 16-19 11/14/2014
Immunomedics, Inc. (IMMU) Announces Six Presentations On Epratuzumab In Lupus At Leading Rheumatology Meeting 11/14/2014
Dr. Remy Luthringer. Minerva Neurosciences, Inc. (NERV) President And Chief Scientific Officer, To Present At CNS Summit 11/14/2014
Celiac Disease Center At Columbia University Unveils Video Campaign At 13th Anniversary Gala To Demonstrate The Severity Of Celiac Disease For Patients 11/14/2014
Algenol Biofuels Selected To Present At CleanEquity Monaco 2015 11/14/2014
Merz North America Job Fair To Be Held At North Carolina Biotechnology Center 11/14/2014
Verastem, Inc. (VSTM) To Present Data At The 2014 EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/14/2014
Baxter International, Inc. (BAX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/14/2014
Dr. Martine Dehlinger-Kremer, Global Vice President Medical And Regulatory Affairs For SynteracHCR, To Speak On Pediatric Research At Pharmig/OKIDS Conference In Vienna 11/14/2014
BEAT BioTherapeutics Announces Scientific Presentations Of Promising New Heart Failure Treatment At The American Heart Association Meeting 11/14/2014
The Medicines Company (MDCO) To Present New Data On Investigational Lipid-Modifying Agent MDCO-216 And Investigational Antiplatelet Agent Cangrelor At 2014 American Heart Association Annual Scientific Sessions In Chicago 11/14/2014
Merrimack Pharmaceuticals Inc. (MACK) To Present Advances On Targeted Cancer Molecules At The 2014 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer International Conference 11/14/2014
Hyperion Therapeutics (HPTX) To Present At The Jefferies and Co. 2014 Global London Healthcare Conference 11/14/2014
Keryx Biopharmaceuticals (KERX) To Present At The Stifel 2014 Healthcare Conference 11/14/2014
ERYtech Pharma To Present At Jefferies and Co. Global Healthcare Conference 11/14/2014
Tokai Pharmaceuticals (TKAI) To Ring The Nasdaq Stock Market Opening Bell 11/14/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Presentation At Jefferies and Co. 2014 Global Healthcare Conference In London 11/14/2014
Forward Pharma (FWP) CFO To Present At Two Upcoming Conferences 11/14/2014
Celladon Corporation Selected To Present During The "Best Of Circulation Research" Symposium At The American Heart Association Scientific Sessions 2014 11/14/2014
Aceto Corporation To Present At Two Upcoming Investment Conferences 11/14/2014
Acorda Therapeutics (ACOR) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/14/2014
Ablynx (ABLYF) To Present Data On Its Anti-Il-6r Nanobody, Developed In Partnership With AbbVie (ABBV), At The American College of Rheumatology Annual Meeting 11/14/2014
Mesoblast Limited (MSB.AX)'s Phase 2 Trial Results In Chronic Low Back Pain Presented At North American Spine Society Annual Meeting 11/13/2014
Amgen (AMGN) To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab 11/13/2014
Amgen (AMGN) To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions 11/13/2014
BioDelivery Sciences International (BDSI) To Present At The Stifel 2014 Healthcare Conference And The Jefferies and Co. 2014 Global Healthcare Conference 11/13/2014
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Present Recently Released Positive Data From Its Rheumatoid Arthritis Phase 2b Study At The 2014 Can-Fite BioPharma (CFBI) Annual Meeting 11/13/2014
AcelRx Pharmaceuticals (ACRX) Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting 11/13/2014
Arena Pharmaceuticals, Inc. (ARNA) To Present At Stifel 2014 Healthcare Conference 11/13/2014
BioSpecifics Technologies Corporation (BSTC) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
AbbVie (ABBV)'s Leadership In Immunology Featured At 2014 American College of Rheumatology Annual Meeting With New Data On Investigational Medicines And HUMIRA® (adalimumab) 11/13/2014
BioPh China 2015 Gears Up As The Best Platform For Branding, Trading And Barnstorming 11/13/2014
CuVerro® Introduces New Bactericidal Product Line Up At Healthcare Design Conference 11/13/2014
Bioniche Life Sciences Inc. (BNC) Announces Results Of Annual General Meeting Of Shareholders 11/13/2014
EnteroMedics (ETRM) To Participate At The 2014 Canaccord Genuity Medical Technology And Diagnostics Forum 11/13/2014
HeartWare (HTWR) Presentation At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum To Be Webcast 11/13/2014
Dow Outlines Next Layer Of Strategic Actions At Investor Forum 2014 11/13/2014
Zogenix, Inc. (ZGNX) To Participate In Stifel 2014 Healthcare Conference 11/13/2014
Cure Duchenne And ProSensa Holding N.V. (RNA) To Present Collaboration At Partnering For Cures Conference 11/13/2014
Parnell Pharmaceuticals Holdings To Present At Upcoming Investor Conferences 11/13/2014
Tekmira (TKMR) To Present At Stifel Healthcare Conference 11/13/2014
Galena Biopharma  (GALE) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
Synta Pharmaceuticals (SNTA) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
Idera Pharmaceuticals, Inc. (IDRA) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
Results From Phase 2 Study Of GCS-100 In Chronic Kidney Disease Being Presented At American Society of Nephrology Kidney Week 11/13/2014
Esperion Therapeutics, Inc. (ESPR) To Present At Stifel 2014 Healthcare Conference 11/13/2014
Verastem, Inc. (VSTM) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/13/2014
Novavax, Inc. (NVAX) To Present At The Jefferies and Co. Global Healthcare Conference 11/13/2014
Ophthotech Corporation (OPHT) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
Avalanche Biotechnologies (AAVL) To Present At The Jefferies and Co. Global Healthcare Conference 11/13/2014
Immune Design Corporation (IMDZ) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/13/2014
ArQule, Inc. (ARQL) Announces Data Presentations With Pipeline Products To Be Featured At 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/13/2014
Aldeyra Therapeutics (ALDX) To Present At The Therapeutic Area Partnerships Meeting 11/13/2014
Blueprint Medicines To Present Discovery Of New Cancer Drug Targets At EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/13/2014
Tolero Pharmaceuticals Presents Positive Preclinical Data On Programs In Leukemia And Anemia At The 56th American Society of Hematology Annual Meeting And Exposition 11/13/2014
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Jefferies and Co. 2014 Global Healthcare Conference On November 20, 2014 11/13/2014
NephroGenex (NRX) Announces Presentation At The American Society of Nephrology’s Kidney Week 2014 11/13/2014
Horizon Pharma plc.  (HZNP) Announces Clinical Data On RAYOS® (Prednisone) Delayed-Release Tablets And VIMOVO(R) (Naproxen/Esomeprazole Magnesium) To Be Presented At American College of Rheumatology Annual Meeting 11/13/2014
VBL Therapeutics (VBLX) To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At 19th Annual Scientific Meeting Of The Society For Neuro-Oncology (SNO) 11/13/2014
Theravance Biopharma To Present At The Stifel Healthcare Conference On November 18th 11/13/2014
Horizon Pharma plc.  (HZNP) To Present At The Stifel 2014 Healthcare Conference 11/13/2014
PDL BioPharma, Inc. (PDLI) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/12/2014



//-->